Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5549892 | GENZYME | Enhanced in vivo uptake of glucocerebrosidase |
Aug, 2013
(10 years ago) |
Market Authorisation Date: 23 May, 1994
Treatment: Method of treating a human subject having gaucher's disease
Dosage: INJECTABLE;INJECTION